<bill session="114" type="h" number="298" updated="2018-11-21T21:22:57Z">
  <state datetime="2015-01-13">REFERRED</state>
  <status>
    <introduced datetime="2015-01-13"/>
  </status>
  <introduced datetime="2015-01-13"/>
  <titles>
    <title type="short" as="introduced">Medical Testing Availability Act of 2015</title>
    <title type="official" as="introduced">To amend chapter V of the Federal Food, Drug, and Cosmetic Act to permit the sale of, and access to, "research use only" products.</title>
    <title type="display">Medical Testing Availability Act of 2015</title>
  </titles>
  <sponsor bioguide_id="B001248"/>
  <cosponsors>
    <cosponsor bioguide_id="S001175" joined="2015-01-13"/>
  </cosponsors>
  <actions>
    <action datetime="2015-01-13">
      <text>Introduced in House</text>
    </action>
    <action datetime="2015-01-13" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2015-01-16">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="HSIF" name="House Energy and Commerce" activity="Referral"/>
    <committee subcommittee="Health" code="HSIF14" name="House Energy and Commerce" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Consumer affairs"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Health technology, devices, supplies"/>
    <term name="Medical research"/>
    <term name="Product safety and quality"/>
  </subjects>
  <amendments/>
  <summary date="2015-01-13T05:00:00Z" status="Introduced in House">Medical Testing Availability Act of 2015

This bill amends the Federal Food, Drug, and Cosmetic Act to prohibit a product labeled for research use only from being deemed adulterated or misbranded on the basis that its manufacturer or distributor: (1) sells the product to an end user who uses the product for a purpose other than research, or (2) engages in business communications with an end user regarding the product.</summary>
  <committee-reports/>
</bill>
